Pathogenesis of fibrosis: Type 1 collagen and the skin

Journal of Molecular Medicine

Volumn 76, Issue 3-4, 1998, Pages 266-274

  Trojanowska, Maria ^c,d,e,f   LeRoy, E Carwile ^f,g   Eckes, Beate ^g   Krieg, Thomas ^a,b,g  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY OF WARSAW   (Poland)

^d POLISH ACADEMY OF SCIENCES   (Poland)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Collagen type I; Cytokines; Fibrosis; Integrins; Transcriptional regulation

Indexed keywords

COLLAGEN TYPE 1; CYTOKINE; INTEGRIN; MATRIX METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR;

CELL FUNCTION; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSIS; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PATHOGENESIS; REVIEW; TISSUE REPAIR; TRANSCRIPTION REGULATION;

CELL ADHESION; COLLAGEN; CYTOKINES; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; SKIN;

EID: 0031911238     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050216     Document Type: Review

References (100)

1. Fleischmajer R, Perlish JS, West WP (1977) Ultrastructure of cutaneous infiltrates in scleroderma. Arch Dermatol 113: 1661-1666
2. Maquart FX, Gillery P, Kalis B, Borel JP (1994) Cytokines and fibrosis. Eur J Dermatol 4:91-97
3. Postlethwaite AE (1995) Role of T cells and cytokines in effecting fibrosis. Int Rev Immunol 12:247-258
4. Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T (1990) Co-localization of transforming growth factor-β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic scleroderma. J Clin Invest 86:917-922
5. LeRoy EC (1972) Connective tissue synthesis by scleroderma skin fibroblasts in cell culture. J Exp Med 135:1351-1362
6. Uitto J, Bauer EA, Eisen AZ (1979) Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest 64:921-930
7. Jiménez SA, Feldman G, Bashey RI, Bienkowski R, Rosenbloom J (1986) Coordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts. Biochem J 237:837-843
8. Eckes B, Manch C, Huppe G, Krieg T (1996) Differential regulation of transcription and transcript stability of pro-α(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem J 315:549-554
9. Prockop DJ, Kivirikko KI (1995) Collagens: molecular biology, diseases and potentials for therapy. Ann Rev Biochem 64:403-434
10. Auniailley M, Krieg T (1996) Laminins: a family of diverse multifunctional molecules of basement membranes. J Invest Dermatol 106:209-214
11. Iozzo RV, Cohen IR, Grassel S, Murdoch AD (1994) The biology of perlecan: the multifaceted heparan sulfate proteoglycan of basement membranes and pericellular matrices. Biochem J 302:625-639
12. Faull RJ (1995) Adhesion molecules in health and disease. Aust NZ J Med 25:720-730
13. Bornstein P, Sage H (1989) Regulation of collagen sene expression. Prog Nucleic Acid Res Mol Biol 37:67-106
14. Ramirez F, Di Liberto M (1990) Complex and diversified regulalorv programs control the expression of vertebrate collagen genes. FASEB J 4:1616-1623
15. Slack JL, Liska DJ, Bornstein P (1993) Regulation of expression of the type I collagen genes. Am J Med Gen 45:140-151
16. Karsenty G, Park RW (1995) Regulation of type I collagen genes expression. Intern Rev Immunol 12:177-185
17. Boast S, Su M-W, Ramirez F, Sanchez M, Avvedimento EV (1990) Functional analysis of cis-acting DNA sequences controlling transcription of the human type I collagen genes. J Biol Chem 265:13351-13356
18. Tamaki T, Ohnishi K, Hartl C, LeRoy EC, Trojanowska M (1995) Characterization of a GC-rich region containing Sp1 binding site(s) as a constitutive responsive element of the α2(I) collagen gene in human fibroblasts. J Biol Chem 270:4299-4304
19. Ihn H, Ohnishi K, Tamaki T, LeRoy EC, Trojanowska M (1996) Transcriptional regulation ot the human α2(I) collagen gene. Combined action of upstream stimulatory and inhibitory cis-acting elements. J Biol Chem 271:26717-26723
20. Ihn H, Trojanowska M (1997) Sp3 is a transcriptional activator of the human α2(I) collagen gene. Nucl Acids Res 25:3712-3717
21. Hasegawa T, Zhou X, Garett LA, Ruteshouser EC, Maity SN, de Crombrugghe B (1996) Evidence for three major transcription activation elements in the proximal mouse proα2(I) collagen promoter. Nucleic Acid Res 24:3253-3260
22. Galéra P, Park R-W, Ducy P, Mattei M-G, Karsenty G (1996) c-Krox binds to several sites in the promoter of both mouse type I collagen genes. J Biol Chem 271:21331-21339
23. Niederreither K, D'Souza RN, de Crombrugghe B (1992) Minimal DNA sequences that control lineage-specific expression of the proα2(I) collagen promoter in transgenic mice. J Cell Biol 119:1361-1370
24. Bou-Gharios G, Garett LA, Rossert J, Niedederreither K, Eberspaechcr H, Smith C, Black C, de Crombrugghe B (1996) A potent tar-upstream enhancer in the mouse proα2(I) collagen gene regulates expression of reporter genes in transgenic mice. J Cell Biol 134:1333-1344
25. Bornstein P (1996) Regulation of expression of the α1(I) collagen gene: a critical appraisal of the role of the first intron. Matrix Biol 15:3-10
26. Maity SN, Golumbek PT, Karsenty G, de Crombrugghe B (1988) Selective activation of transcription by a novel CCAAT binding factor. Science 241:582-585
27. Sinha S, Kim I-S, Sohn K-Y, de Crombrugghe B, Maity SN (1996) Three classes of ululations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex. Mol Cell Biol 16:328-337
28. Coustry F, Maity SN, Sinha S, de Crombrugghe B (1996) The transcriptional activity of the CCAAT-binding factor CBF is mediated by two distinct activation domains, one in the CBF-B subunit and the other in the CBF-C subunit. J Biol Chem 271:14485-14491
29. Nehls MC, Rippe RA, Veloz L, Brenner DA (1991) Transcription factors nuclear factor I and Sp1 interact with the murine collagen α1(I) promoter. Mol and Cell Biol 11:4065-4073
30. Galéra P, Musso M, Ducy P, Karsenty G (1994) cKrox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. Proc Nat Acad Sci USA 91:9372-9376
31. Philips N, Bashey RI, Jiménez SA (1995) Increased α1(I) procollagen gene expression in tight skin (TSK) mice myocardial fibroblasts is due to a reduced interaction of a negative regulatory sequence with AP-I transcription factor. J Biol Chem 270:9313-9321
32. Jiménez SA, Varga J, Olsen A, Li L, Diaz A, Herhal J, Koch J (1994) Functional analysis of human α1(I) procollagen gene promoter. J Biol Chem 269:12684-12691
33. Li L, Arlett CM, Jiménez SA, Hall DJ, Varga J (1995) Positive regulation of human α1(I) collagen promoter activity by transcription factor Spl. Gene 164:229-234
34. Kikuchi K, Hartl CW, Smith EA, LeRoy EC, Trojanowska M (1992) Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGFβ1 stimulation. Biochem Biophys Res Commun 187:45-50
35. Hitraya EG, Jiménez SA (1996) Transcriptional activation of the α1(I) procollagen gene in systemic sclerosis dermal fibroblasts. Arthritis Rheum 39:1347-1354
36. Inagaki Y, Truter S, Greenwel P, Rojkind M, Unoura M, Kobayashi K, Ramirez F (1995) Regulation of the α2(I) collagen gene transcription in fat-storing cells derived from a cirrhotic liver. Hepatol 22:573-579
37. Rippe RA, Almounajed G, Brenner DA (1995) Sp1 binding activity increases in activated lto cells. Hepatol 22:241-251
38. Bateman JF, Lamande SR, Ramshaw JAM (1996) Collagen superfamily. In: WD Comper (ed) Extracellular matrix, vol 2. Harwood, Amsterdam, pp 22-67
39. Emouard H, Grimaud JA (1990) Matrix metalloproteinases. A review. Cell Mol Biol 36:131-153
40. Woessner Jr JF (1991) Metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154
41. Liu X, Wu H, Byrne M, Jeffrey J, Krane S, Jaenisch R (1995) A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol 130:227-237
42. Murphy G, Knäuper V (1997) Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol 15:511-518
43. Benbow U, Brinckerhoff CE (1997) The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 15:519-526
44. Shapiro SD (1997) Mighty mice: transgenic technology "knocks out" questions of matrix metalloproteinase function. Matrix Biol 15:527-533
45. Basset P, Okada A, Chenard M-P, Kannan R, Stoll I, Anglard P, Bellocq JP, Rio M-C (1997) Matrix metalloproteinuses as stromal effectors of human carcinoma progression: therapeutic implications. Matrix Biol 15:535-541
46. Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, Ferrans VJ, Travis WD (1996) Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 149:1241-1256
47. Aumailley M, Krieg T (1994) Structure and function of the cutaneous extracellular matrix. Eur J Dermatol 4:271-280
48. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E (1992) Natural inhibitor of transforming growth factor β protects against scarring in experimental kidney disease. Nature 360:361-364
49. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, Border WA (1996) Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med 2:418-423
50. Aggarwal BB, Puri RK (Eds) (1995) Human cytokines: their role in disease and therapy. Blackwell Science, Cambridge, pp 736
51. Massagué J (1990) The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641
52. Border WA, Ruoslahti E (1992) Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 90:1-7
53. McCartney-Francis NL, Wahl SM (1994) Transforming growth factor-β: a matter of life and death. J Leukocyte Biol 55:401-409
54. Kingsley DM (1994) The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146
55. Saltis J, Agrotis A, Bobik A (1996) Regulation and interactions of transforming growth factor-β with cardiovascular cells: implications for development and disease. Clin Exp Pharm Physiol 23:193-200
56. Schultz-Cherry S, Chen H, Mosher DF, Misenheimer, TM, Kritzsch HC, Roberts DD, Murphy-Ullrich JE (1995) Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1. J Biol Chem 270:7304-7310
57. Yamakage A, Kikuchi K, Smith EA, LeRoy EC, Trojanowska M (1992) Selective upregulation of platelet-derived growth factor a receptors by transforming growth factor-β in scleroderma patients. J Exp Med 175:1227-1234
58. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R (1990) TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515-524
59. Seifert RA, Coats SA, Raines EW, Ross R, Bowen-Pope DF (1994) Platelet-derived growth factor receptor alpha-subunit mutant and reconstituted cell lines demonstrate that transforming growth factor-β can be mitogenic through PDGF A-chain-dependent and -independent pathways. J Biol Chem 269:13951-13955
60. Greenwel P, Hu W, Kohanski RA, Ramirez F (1995) Tyrosine dephosphorylation of nuclear proteins mimics transforming growth factor β stimulation of α2(I) collagen expression. Mol Cell Biol 15:6813-6819
61. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J (1994) Mechanism of activation of the TGF-β receptor. Nature 370:341-347
62. Derynck R (1994) TGF-β-receptor-mediated signaling. Trends Biocheni Sci 19:548-553
63. Laiho M, Weis FMB, Boyd FT, Ignoltz RA, Massagué J (1991) Responsiveness to transforming growth factor-β (TGF-β) restored by genetic complementation between cells defective in TGF-β receptors I and II. J Biol Chem 266:9108-9112
64. Kovacs EJ, Di Pietro LA (1994) Fibrogenic cytokines and connective tissue production. FASEB J 8:854-861
65. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B (1988) A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β. Cell 52:405-414
66. Alevizopoulos A, Dusserre Y, Tsai-Pflugfelder M, der Weid T, Wahli W, and Mermod N (1995) A proline-rich TGF-β-responsive transcriptional activator interacts with histone H3. Genes Dev 9:3051-3066
67. Inagaki Y, Truter S, Ramirez F (1994) Transforming growth factor-β stimulates α2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 269:14828-14834
68. Chung K-Y, Agarwal A, Ditto J, Mauviel A (1996) An AP-1 binding sequence is essential for regulation of the human α2(I) collagen (COL1A2) promoter activity by transforming growth factor-β. J Biol Chem 271:3272-3278
69. Ritzenhaler JD, Goldstein RH, Fine A, Lichtler A, Rowe DW, Smith B (1991) Transforming-grnwth factor-β activation elements in the distal promoter regions of the rat α1 type I collagen gene. Biochem J 280:157-162
70. Ritzenhaler JD, Goldstein RH, Fine A, Smith BD (1993) Regulation of the α1(I) collagen promoter via a transforming growth factor-β activation element. J Biol Chem 268:13625-13631
71. Armendariz-Borunda, Simkevich CP, Roy N, Raghow R, Kang AH, Seyer JM (1994) Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem J 304:817-824
72. Kahan VM, Chen YQ, Su MW, Ramirez F, Uitto J (1990) Tumor necrosis factor-alpha and interleron-γ suppress the activation of human type I collagen gene expression by transforming growth factor-β1. J Clin Invest 86:1489-1495
73. Takeda K, Hatamochi A, Arakawa M, Ueki K (1993) Effect of tumor necrosis factor-alpha on connective tissue metabolism in normal and scleroderma fibroblast cultures. Arch Dermatol Res 284:440-444
74. Inagaki Y, Truter S, Tanaka S, Di Liberto M, Ramirez F (1995) Overlapping pathways mediate the opposing actions of tumor necrosis factor-alpha and transforming growth factor-β on α2(I) collagen gene transcription. J Biol Chem 270:3353-3358
75. Gay S, Jones Jr, RE, Huang G-Q, Gay RE (1989) Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma. J Invest Dermatol 92:301-306
76. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Grotendorst GR, Takehara K (1995) Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 105:280-284
77. Salmon-Ehr V, Serpier H, Nawrocki B, Gillery P, Clavel C, Kalis B, Birembaut P, Maquart FX (1996) Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis. Arch Dermatol 132:802-806
78. Ludwicka A, Ohba T, Trojanowska M, Yamakuge A, Strance C, Smith EA, LeRoy EC, Sutherland S, Silver R (1995) Elevated levels of platelet derived growth factor and transforming growth factor β in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumat 22:1876-1883
79. Ichiki Y, Smith EA, LeRoy EC, Trojanowska M (1995) Different effects of basic fibroblast growth factor and transforming growth factor β on the two platelet-derived growth factor receptors' expression in scleroderma and healthy human dermal fibroblasts. J Invest Dermatol 104:124-127
80. Kikuchi K, Kadano T, Ihn H, Sato S, Igarashi A, Nakagawa H, Tamaki K, Takehara K (1995) Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor β. J Invest Dermatol 105:128-132
81. Paulsson Y, Karlsson C, Heldin C-H, Westemark B (1993) Density-dependent inhibitory effect of transforming growth factor β on human fibroblasts involves the downregulation of platelet-derived growth factor α-receptors. J Cell Phys 157:97-103
82. Haisa M, Okochi H, Bradham DM, Grotendorst GR (1993) Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4:637-645
83. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M, Grotendorst GR, Takehara K (1996) Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106:729-733
84. Igarashi A, Okochi H, Bradham DM, Grotendorst GR (1993) Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4:637-645
85. Postlethwate AR, Holness M, Katai H, Raghow R (1992) Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 90:1479-1485
86. Makhluf HA, Stepniakowska J, Hoffman S, Smith EA, LeRoy EC, Trojanowska M (1996) IL-4 upregulates lenascin synthesis in scleroderma and healthy skin fibroblasts. J Invest Dermatol 107:856-859
87. Lacour JP, Vitetta A, Chiquel-Ehrismann R, Pisani A, Ortonne JP (1992) Increased expression of tenascin in the dermis in scleroderma. Br J Dermatol 127:328-334
88. Duncan MR, Hasan A, Berman B (1995) Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts. J Invest Dermatol 104:128-133
89. Reitamo S, Remitz A, Tamai K, Uitto J (1994) Interleukin-10 modulates collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts. J Clin Invest 94:2489-2492
90. Ichiki Y, Smith EA, LeRoy EC, Trojanowska M (1997) Basic fibroblast growth factor inhibits basal and transforming growth factor-β induced collagen α2(1) gene expression in scleroderma and normal fibroblasts. J Rheumatol 24:90-95
91. Yamada KM, Miyamoto S (1995) Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol 7:681-689
92. 1 integrins. J Cell Biol 131:1903-1915
93. Eckes B, Mauch C, Huppe G, and Krieg T (1993) Downregulation of collagen synthesis in fibroblasts within three-dimensional collagen lattices involves transcriptional and posttranscriptional mechanisms. FEBS 318:129-133
94. Mauch C, Kozlowska E, Eckes B, Krieg T (1992) Altered regulation of collagen metabolism in scleroderma fibroblasts grown within three-dimensional collagen gels. Exp Dermatol 1:185-190
95. Schmidhauser C, Casperson GF, Myers CA, Sanyo KT, Bolten S, Bissell MJ (1992) A novel transcriptional enhancer is involved in the prolactin and ECM-dependent regulation of β-casein gene expression. Mol Biol Cell 3:699-709
96. Shi-Wen X, Demon CP, McWhirter A, Buo-Gharios G, Abraham DJ, duBois RM, Black CM (1997) Scleroderma lung fibroblasts exhibit elevated and dysregulated type I collagen biosynthesis. Arthritis Rheum 40:1237-1244
97. Fries KM, Blieden T, Looney RJ, Scampowski GP, Silvera MR, Willis RA, Phipps RP (1994) Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol 72:283-292
98. Jelaska A, Arakawa M, Broketa G, Korn JH (1996) Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Arthritis Rheum 39:1338-1346
99. Silvera MR, Sempowski GP, Watts H, Penney DP, Phipps RP (1993) Lung fibroblast heterogeneity. J Am Med 6:1-21
100. Ko SD, Paye RL, Narayanan AS (1984) Fibroblast heterogeneity and prostaglandin regulation of subpopulations. Proc Natl Acad Sci USA 74:171-173